Dirhodium(II,II) Complexes:  Molecular Characteristics that Affect in Vitro Activity

Alfredo M. Angeles‐Boza(The Ohio State University), Helen T. Chifotides(The Ohio State University), J. Dafhne Aguirre(United States Food and Drug Administration), A. Chouai(The Ohio State University), Patty K.‐L. Fu(United States Food and Drug Administration), Kim R. Dunbar(The Ohio State University), Claudia Turró(United States Food and Drug Administration)
Journal of Medicinal Chemistry
October 26, 2006
Cited by 121

Abstract

In the series Rh2(O2CR)4 (R=CH3, 1; R=CF3, 2), [Rh2(O2CR)2(phen)2]2+ (R=CH3, 3; R=CF3, 4), and [Rh2(O2CR)2(dppz)2]2+ (R=CH3, 5; R=CF3, 6), 2, 4, and 6 are twice as cytotoxic as 1, 3, and 5, respectively. The substitution reactions of 2 with 9-ethylguanine at various temperatures take place at faster rates than those of 1, and the activation energy Ea(1)=69+/-4 kJ/mol is twice Ea(2)=35+/-2 kJ/mol. The higher cytotoxicities of [Rh2(micro-O2CCH3)2(eta1-O2CCH3)L(MeOH)]+ (L=dppz, 7; L=dppn, 8) relative to [Rh2(micro-O2CCH3)2(bpy)L]2+ (L=dppz, 10; L=dppn, 11) are attributed to the labile equatorial groups in 7 and 8 not present in 10 and 11. The toxicities of complexes 1-8 are not related to their charge or the ease by which they transverse the cellular membrane but to the lability of the ligands on the dirhodium core.


Related Papers

No related papers found

Powered by citation graph analysis